Docstoc

2013 | Aarkstore.in || Opioid-Induced Constipation (OIC) – Pipeline Review, H2 2012

Document Sample
2013 | Aarkstore.in || Opioid-Induced Constipation (OIC) – Pipeline Review, H2 2012 Powered By Docstoc
					You can also request for sample page of above
mention reports on Customersupport@aarkstore.com
Price :
$ 2000 - PDF | $ 4000 - Site Licence | $ 6000 - Corporate Licence


Pages : 77
Summary


 Global Markets Direct’s, Opioid-Induced Constipation (OIC) - Pipeline Review,
H2 2012, provides an overview of the indication’s therapeutic pipeline. This
report provides information on the therapeutic development for Opioid-Induced
Constipation (OIC), complete with latest updates, and special features on late-
stage and discontinued projects. It also reviews key players involved in the
therapeutic development for Opioid-Induced Constipation (OIC). Opioid-
Induced Constipation (OIC) - Pipeline Review, Half Year is built using data and
information sourced from Global Markets Direct’s proprietary databases,
Company/University websites, SEC filings, investor presentations and featured
press releases from company/university sites and industry-specific third party
sources, put together by Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the
availability and relevance of data for the indicated disease.
Scope

 - A snapshot of the global therapeutic scenario for Opioid-Induced Constipation
(OIC).
 - A review of the Opioid-Induced Constipation (OIC) products under
development by companies and universities/research institutes based on
information derived from company and industry-specific sources.
 - Coverage of products based on various stages of development ranging from
discovery till registration stages.

Reasons to buy

- Identify and understand important and diverse types of therapeutics under
development for Opioid-Induced Constipation (OIC).
- Identify emerging players with potentially strong product portfolio and design
effective counter-strategies to gain competitive advantage.
- Plan mergers and acquisitions effectively by identifying players of the most
promising pipeline.
Table Of Contents

List of Tables 5
List of Figures 5
Introduction 6
Global Markets Direct Report Coverage 6
Opioid-Induced Constipation (OIC) Overview 7
Therapeutics Development 8
An Overview of Pipeline Products for Opioid-Induced Constipation (OIC) 8
Opioid-Induced Constipation (OIC) Therapeutics under Development by
Companies 10
Opioid-Induced Constipation (OIC) Therapeutics under Investigation by
Universities/Institutes 12
Late Stage Products 13
Comparative Analysis 13
Mid Clinical Stage Products 14
Comparative Analysis 14
Early Clinical Stage Products 15
Comparative Analysis 15
Pre-Clinical Stage Products 16
Comparative Analysis 16………………..
More Related Reports:

http://www.aarkstore.com/publishers/pubreports.asp?PubId=4
9&pagenum=1

Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ) – Pipeline
Review, H2 2012

Basal Cell Carcinoma (Basal Cell Epithelioma) – Pipeline Review, H2
2012

Diabetic Peripheral Neuropathy – Pipeline Review, H2 2012

Opioid-Induced Constipation (OIC) – Pipeline Review, H2 2012

Premature Labor (Tocolysis) – Pipeline Review, H2 2012
For More details about above & other Reports
plz contact :


Lavanya
Aarkstore.com


Contact: Marketing team
Mob.No.918149852585
Email: enquiry@aarkstore.com
URL: http://www.aarkstore.com
http://in.linkedin.com/in/aarkstore
http://www.facebook.com/aarkstore

				
DOCUMENT INFO
Shared By:
Categories:
Stats:
views:2
posted:1/4/2013
language:
pages:7